Skip to main content
. 2018 Jul 11;16(3):3635–3641. doi: 10.3892/ol.2018.9138

Figure 4.

Figure 4.

DNM1L confers poor prognosis in patients with gastric adenocarcinoma. (A) Immunohistochemical staining for DNM1L in carcinoma specimens (magnification, ×200). (B) Immunohistochemical staining for DNM1L in pericarcinoma specimens (magnification, ×200). (C) Frequency of DNM1L expression in carcinoma and pericarcinoma specimens (n=150), (D) Kaplan-Meier curves of the overall survival of patients negative or positive for DNM1L expression (P=0.0059). DNM1L, dynamin-1-like protein.